Day 15 bone marrow minimal residual disease predicts response to blinatumomab in relapsed/refractory paediatric B-ALL

Patrick Brown, Gerhard Zugmaier, Lia Gore, Catherine A. Tuglus, Arend von Stackelberg

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)e36-e39
JournalBritish journal of haematology
Volume188
Issue number4
DOIs
StatePublished - Feb 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this